entertainment -WSS

entertainment

author：hotspot 2025-09-30 00:50:21 - browse：99739

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Ukraine seeks to reclaim its role as a hub for clinical trials

WSS

Researchers tackle phage therapy hurdles for wider adoption

Medicare Advantage enrollment hits roughly 33.4 million

Congress may force more Covid

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

New Medicare drug pricing powers could soon be upended in court

Obamacare plans could cover weight loss drugs

hotspot

entertainment

Wikipedia

Medical records are filled with copy

Caregivers of transplant patients call for more support, training

After affirmative action ruling, medical educators look to 'holistic review'

Heart disease and mental health: A look at cardiac psychology

Drug repurposing or repositioning? The language matters

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

23andMe had bad news about my health. I wish a person had delivered it

Designating disabled people as health disparity population is crucial

Sports medicine is finally prioritizing gender equality

The nurse manager staffing crisis is hurting patients

Wikipedia

Ukraine seeks to reclaim its role as a hub for clinical trials

As JPM 2024 winds down, some health tech firms project optimism

Designating disabled people as health disparity population is crucial

Idaho abortion case may prompt more restrictions in other states

Flagship Pioneering startup Sonata Therapeutics lays off 21

Risky weight loss products often used by teens globally, per study

knowledge

focus

hotspot

entertainment